%0 Journal Article %J Archives of Medical Science %@ 1734-1922 %V 15 %N 4 %D 2019 %F Cicero2019 %T Resveratrol and cognitive decline: a clinician perspective %X Resveratrol (3,5,4-trihydroxystilbene) belongs to a family of polyphenolic compounds known as stilbenes, particularly concentrated in grape and red wine. The aim of our review was to critically review the available evidence of resveratrol effects on brain function and its potential impact on therapy. In preclinical models of cognitive decline, resveratrol displays potent antioxidant activity by scavenging free radicals, reducing quinone reductase 2 activity and upregulating endogenous enzymes. Resveratrol also inhibits pro-inflammatory enzyme expression, reduces nuclear factor-B activation and cytokine release. Treatment with resveratrol can affect multiple signaling pathway effectors involved in cell survival, programmed cell death and synaptic plasticity. Direct and/or indirect activation of the deacetylase sirtuins by resveratrol has also been suggested. In humans, clinical evidence derived from randomized clinical trials suggests that resveratrol is able to improve cerebral blood flow, cerebral vasodilator responsiveness to hypercapnia, some cognitive tests, perceived performances, and the A40 plasma and cerebrospinal fluid level. %A Cicero, Arrigo F.G. %A Ruscica, Massimiliano %A Banach, Maciej %P 936-943 %9 journal article %R 10.5114/aoms.2019.85463 %U http://dx.doi.org/10.5114/aoms.2019.85463